U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07747025) titled 'Nurse-Led Motivational Interviewing for Blood Pressure Control' on July 30. Brief Summary: ... Read More
U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07747142) titled 'Comparison Between Opioid-sparing Anesthesia Guided by the CARDEAN(R) Index and Opioid-free ... Read More
U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07746531) titled 'Robotic Minimally Invasive Benign Hysterectomy Post-market Clinical Study With the DEXTER Ro... Read More
U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07747532) titled 'Reliability of Diaphragm Ultrasound: Intra- and Interrater Analysis' on July 21. Brief Summ... Read More
U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07746440) titled 'Impact of Cannabis Use and Abstinence on Emotion' on July 30. Brief Summary: The goal of th... Read More
U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07748377) titled 'Increasing Breast and Colorectal Cancer Screening in the Community' on July 31. Brief Summa... Read More
U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07747909) titled 'Effect of Orlistat on Metabolic and Hormonal Features in Women With Polycystic Ovary Syndrom... Read More
U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07746921) titled 'Smart Inhaler and Remote Asthma Management in Adolescents With Intellectual and Developmenta... Read More
U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07748052) titled 'Strength Training Combined With Blood Flow Restriction and Cerebral Palsy' on July 30. Brie... Read More
U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07746583) titled 'A Study of Guselkumab Given After Ustekinumab in Participants With Moderate to Severe Psoria... Read More